Skip to main content
Integrated Proteins Ltd. logo

Integrated Proteins Ltd. — Investor Relations & Filings

Ticker · 519606 ISIN · INE177M01013 BSE.NS Manufacturing
Filings indexed 308 across all filing types
Latest filing 2023-03-31 Board/Management Inform…
Country IN India
Listing BSE.NS 519606

About Integrated Proteins Ltd.

https://www.integratedproteins.com/

Integrated Proteins Ltd. specializes in the processing and manufacturing of protein-rich products and edible oils. The company operates a solvent extraction plant focused on the production of de-oiled cakes and refined oils, primarily derived from soybeans and other oilseeds. Its core activities include the extraction of high-quality vegetable proteins used extensively in the animal feed industry, particularly for poultry and aquaculture. The company maintains integrated facilities to ensure quality control throughout the production cycle, from raw material sourcing to the final extraction process. By leveraging advanced solvent extraction technology, Integrated Proteins Ltd. produces nutrient-dense soy meal and refined vegetable oils that serve both domestic and international food and feed sectors. The organization emphasizes technical efficiency and product consistency to meet the rigorous standards of the global protein market.

Recent filings

Filing Released Lang Actions
With reference to Regulation 30 of SEBI(LODR) , The Board of Directors at their meeting held on Friday, 31st March, 2023, inter-alia considered and approved the following; 1. Change in ....
Board/Management Information Classification · 100% confidence The document is an official announcement addressed to the stock exchange (BSE Limited) under Regulation 30(2) of SEBI (LODR) Regulations, 2015. It details changes in the company's board of directors and senior management, specifically the change in designation of Mr. Arvind K. Shah from Managing Director to Non-Executive Director and the appointment of Mr. Chintan Arvindbhai Shah as Additional Director and Managing Director. The document includes details such as dates, terms of appointment, brief profiles, and shareholding information related to these changes. There is no financial data, earnings information, or report publication mentioned. The content clearly fits the category of Board/Management Information (MANG) as it announces changes in the company's board and senior management positions.
2023-03-31 English
Pursuant to the provisions of Regulation 30 (read with Part A of Schedule III) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we hereby ....
Regulatory Filings
2023-02-06 English
Pursuant to the provisions of Regulation 30 (read with Part A of Schedule III) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we hereby ....
Earnings Release Classification · 95% confidence The document is a short announcement from Integrated Proteins Limited reporting the outcome of a Board Meeting held on 6th February 2023. It specifically mentions the approval of unaudited financial results for the quarter ended 6th February 2023 along with a Limited Review Report by the Auditors. The document is brief (1496 characters) and serves as a notification of the financial results approval rather than containing the full financial statements or detailed analysis. According to the rules, such brief announcements of quarterly financial results are classified as Earnings Release (ER). Q3 2023
2023-02-06 English
INTEGRATED PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2023 ,inter alia, to consider and approve considering and approving ....
Regulatory Filings Classification · 95% confidence The document is a short notice informing about a scheduled board meeting to approve unaudited financial results for the quarter ended December 31, 2022, and mentions the trading window closure and reopening. It does not contain any financial data or results itself, nor does it include detailed financial statements or analysis. The document is essentially an announcement of an upcoming event related to financial reporting, not the report itself. The length is only 1456 characters, which is quite short and consistent with an announcement rather than a full report. Therefore, according to the MENU VS MEAL RULE, this is a Regulatory Filing (RNS) as a general regulatory announcement about the board meeting and financial results approval schedule.
2023-01-30 English
PFA the certificate under Regulation 74(5) of SEBI(DP) Regulations, 2019 for the quarter ended December 2022. Thank you
Regulatory Filings
2023-01-15 English
Revised outcome This is with reference to the Corporate Announcement submitted by Company dated 10-Nov-2022 . The Revised Outcome is hereby filed by complying with Regulation 30 and ....
Regulatory Filings
2022-11-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.